Nilesh Pareek1,2, Peter Kordis3, Nicholas Beckley-Hoelscher4, Dominic Pimenta5, Spela Tadel Kocjancic3, Anja Jazbec3, Joanne Nevett6, Rachael Fothergill6, Sundeep Kalra5, Tim Lockie5, Ajay M Shah1,2, Jonathan Byrne1,2, Marko Noc3, Philip MacCarthy1,2. 1. Department of Cardiology, King's College Hospital NHS Foundation Trust, Denmark Hill, London SE59RS, UK. 2. School of Cardiovascular Medicine and Sciences, BHF Centre of Excellence, King's College London, 125 Coldharbour Lane, London SE5 9NU, UK. 3. Centre for Intensive Internal Medicine, University Medical Center, Zaloska 7, Ljubljana 1000, Slovenia. 4. School of Population Health and Environmental Sciences, King's College London, London SE1 1UL, UK. 5. Department of Cardiology, Royal Free Hospital NHS Foundation Trust, Pond St, Hampstead, London NW3 2QG, UK. 6. London Ambulance Service NHS Trust, 220 Waterloo Rd, London SE1 8SD, UK.
Abstract
AIMS: The purpose of this study was to develop a practical risk score to predict poor neurological outcome after out-of-hospital cardiac arrest (OOHCA) for use on arrival to a Heart Attack Centre. METHODS AND RESULTS: From May 2012 to December 2017, 1055 patients had OOHCA in our region, of whom 373 patients were included in the King's Out of Hospital Cardiac Arrest Registry (KOCAR). We performed prediction modelling with multivariable logistic regression to identify predictors of the primary outcome to derive a risk score. This was externally validated in two independent cohorts comprising 473 patients. The primary endpoint was poor neurological outcome at 6-month follow-up (Cerebral Performance Category 3-5). Seven independent predictors of outcome were identified: missed (unwitnessed) arrest, initial non-shockable rhythm, non-reactivity of pupils, age (60-80 years-1 point; >80 years-3 points), changing intra-arrest rhythms, low pH <7.20, and epinephrine administration (2 points). The MIRACLE2 score had an area under the curve (AUC) of 0.90 in the development and 0.84/0.91 in the validation cohorts. Three risk groups were defined-low risk (MIRACLE2 ≤2-5.6% risk of poor outcome); intermediate risk (MIRACLE2 of 3-4-55.4% of poor outcome); and high risk (MIRACLE2 ≥5-92.3% risk of poor outcome). The MIRACLE2 score had superior discrimination than the OHCA [median AUC 0.83 (0.818-0.840); P < 0.001] and Cardiac Arrest Hospital Prognosis models [median AUC 0.87 (0.860-0.870; P = 0.001] and equivalent performance with the Target Temperature Management score [median AUC 0.88 (0.876-0.887); P = 0.092]. CONCLUSIONS: The MIRACLE2 is a practical risk score for early accurate prediction of poor neurological outcome after OOHCA, which has been developed for simplicity of use on admission. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The purpose of this study was to develop a practical risk score to predict poor neurological outcome after out-of-hospital cardiac arrest (OOHCA) for use on arrival to a Heart Attack Centre. METHODS AND RESULTS: From May 2012 to December 2017, 1055 patients had OOHCA in our region, of whom 373 patients were included in the King's Out of Hospital Cardiac Arrest Registry (KOCAR). We performed prediction modelling with multivariable logistic regression to identify predictors of the primary outcome to derive a risk score. This was externally validated in two independent cohorts comprising 473 patients. The primary endpoint was poor neurological outcome at 6-month follow-up (Cerebral Performance Category 3-5). Seven independent predictors of outcome were identified: missed (unwitnessed) arrest, initial non-shockable rhythm, non-reactivity of pupils, age (60-80 years-1 point; >80 years-3 points), changing intra-arrest rhythms, low pH <7.20, and epinephrine administration (2 points). The MIRACLE2 score had an area under the curve (AUC) of 0.90 in the development and 0.84/0.91 in the validation cohorts. Three risk groups were defined-low risk (MIRACLE2 ≤2-5.6% risk of poor outcome); intermediate risk (MIRACLE2 of 3-4-55.4% of poor outcome); and high risk (MIRACLE2 ≥5-92.3% risk of poor outcome). The MIRACLE2 score had superior discrimination than the OHCA [median AUC 0.83 (0.818-0.840); P < 0.001] and Cardiac Arrest Hospital Prognosis models [median AUC 0.87 (0.860-0.870; P = 0.001] and equivalent performance with the Target Temperature Management score [median AUC 0.88 (0.876-0.887); P = 0.092]. CONCLUSIONS: The MIRACLE2 is a practical risk score for early accurate prediction of poor neurological outcome after OOHCA, which has been developed for simplicity of use on admission. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Timothy N Jones; Matthew Kelham; Krishnaraj S Rathod; Charles J Knight; Alastair Proudfoot; Ajay K Jain; Andrew Wragg; Muhiddin Ozkor; Paul Rees; Oliver Guttmann; Andreas Baumbach; Anthony Mathur; Daniel A Jones Journal: Am J Cardiovasc Dis Date: 2021-12-15
Authors: Hyouk Jae Lim; Young Sun Ro; Ki Hong Kim; Jeong Ho Park; Ki Jeong Hong; Kyoung Jun Song; Sang Do Shin Journal: J Clin Med Date: 2021-12-29 Impact factor: 4.241
Authors: Ji Woong Kim; Juhyung Ha; Taerim Kim; Hee Yoon; Sung Yeon Hwang; Ik Joon Jo; Tae Gun Shin; Min Seob Sim; Kyunga Kim; Won Chul Cha Journal: J Med Internet Res Date: 2021-07-05 Impact factor: 7.076
Authors: Wan Young Heo; Yong Hun Jung; Hyoung Youn Lee; Kyung Woon Jeung; Byung Kook Lee; Chun Song Youn; Seung Pill Choi; Kyu Nam Park; Yong Il Min Journal: PLoS One Date: 2022-04-01 Impact factor: 3.240
Authors: René Blatter; Simon A Amacher; Chantal Bohren; Christoph Becker; Katharina Beck; Sebastian Gross; Kai Tisljar; Raoul Sutter; Stephan Marsch; Sabina Hunziker Journal: Ann Intensive Care Date: 2022-08-17 Impact factor: 10.318
Authors: Edward Baker; Ceri Battle; Abhishek Banjeri; Edward Carlton; Christine Dixon; Jennifer Ferry; Philip Hopkins; Robert Jones; Trevor Murrells; Christine Norton; Lee Patient; Ashraf Rasheed; Imogen Skene; Andrew Tabner; Malcolm Tunnicliff; Louise Young; Andreas Xyrichis; Gerry Lee Journal: BMJ Open Date: 2021-07-08 Impact factor: 2.692